BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38248870)

  • 1. Lipidated brush-PEG polymers as low molecular weight pulmonary drug delivery platforms.
    Kaminskas LM; Butcher NJ; Subasic CN; Kothapalli A; Haque S; Grace JL; Morsdorf A; Blanchfield JT; Whittaker AK; Quinn JF; Whittaker MR
    Expert Opin Drug Deliv; 2024; 21(1):151-167. PubMed ID: 38248870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity.
    Ediriweera GR; Butcher NJ; Kothapalli A; Zhao J; Blanchfield JT; Subasic CN; Grace JL; Fu C; Tan X; Quinn JF; Ascher DB; Whittaker MR; Whittaker AK; Kaminskas LM
    Biomater Sci; 2024 May; 12(11):2978-2992. PubMed ID: 38683548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalisation of brush polyethylene glycol polymers with specific lipids extends their elimination half-life through association with natural lipid trafficking pathways.
    Abdallah M; Lin L; Styles IK; Mörsdorf A; Grace JL; Gracia G; Nowell C; Quinn JF; Landersdorfer CB; Whittaker MR; Trevaskis NL
    Acta Biomater; 2024 Jan; 174():191-205. PubMed ID: 38086497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of conjugation to different lipids on the lymphatic uptake and biodistribution of brush PEG polymers.
    Abdallah M; Lin L; Styles IK; Mörsdorf A; Grace JL; Gracia G; Landersdorfer CB; Nowell CJ; Quinn JF; Whittaker MR; Trevaskis NL
    J Control Release; 2024 May; 369():146-162. PubMed ID: 38513730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of endogenous albumin trafficking pathways in the lungs has potential to modestly increase the lung interstitial access and absorption of drug delivery systems after inhaled administration.
    Ibrahim JP; Butcher NJ; Kothapalli A; Subasic CN; Blanchfield JT; Whittaker AK; Whittaker MR; Kaminskas LM
    Expert Opin Drug Deliv; 2023; 20(8):1145-1155. PubMed ID: 37535434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of polyethylene glycol (PEG) polymers: the effect of PEG size on permeability.
    Gursahani H; Riggs-Sauthier J; Pfeiffer J; Lechuga-Ballesteros D; Fishburn CS
    J Pharm Sci; 2009 Aug; 98(8):2847-56. PubMed ID: 19408293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of poly(ethylene glycol) coating and monomer type on poly(alkyl cyanoacrylate) nanoparticle interactions with lipid monolayers and cells.
    Baghirov H; Melikishvili S; Mørch Y; Sulheim E; Åslund AKO; Hianik T; de Lange Davies C
    Colloids Surf B Biointerfaces; 2017 Feb; 150():373-383. PubMed ID: 27842930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol.
    Jackson MA; Werfel TA; Curvino EJ; Yu F; Kavanaugh TE; Sarett SM; Dockery MD; Kilchrist KV; Jackson AN; Giorgio TD; Duvall CL
    ACS Nano; 2017 Jun; 11(6):5680-5696. PubMed ID: 28548843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation.
    Patil HP; Freches D; Karmani L; Duncan GA; Ucakar B; Suk JS; Hanes J; Gallez B; Vanbever R
    J Control Release; 2018 Feb; 272():62-71. PubMed ID: 29247664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local inflammation alters the lung disposition of a drug loaded pegylated liposome after pulmonary dosing to rats.
    Haque S; Feeney O; Meeusen E; Boyd BJ; McIntosh MP; Pouton CW; Whittaker M; Kaminskas LM
    J Control Release; 2019 Aug; 307():32-43. PubMed ID: 31152749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the synthesis of mucus permeating nanocarriers.
    Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of
    Shang S; Kats D; Cao L; Morgun E; Velluto D; He Y; Xu Q; Wang CR; Scott EA
    Front Immunol; 2018; 9():2709. PubMed ID: 30538700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted binding of PLA microparticles with lipid-PEG-tethered ligands.
    Duncanson WJ; Figa MA; Hallock K; Zalipsky S; Hamilton JA; Wong JY
    Biomaterials; 2007 Nov; 28(33):4991-9. PubMed ID: 17707503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrophobic Domain Structure of Linear-Dendritic Poly(ethylene glycol) Lipids Affects RNA Delivery of Lipid Nanoparticles.
    Zhou K; Johnson LT; Xiong H; Barrios S; Minnig JT; Yan Y; Abram B; Yu X; Siegwart DJ
    Mol Pharm; 2020 May; 17(5):1575-1585. PubMed ID: 32267707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of polymer size and charge of molecules on permeation through synovial membrane and accumulation in hyaline articular cartilage.
    Sterner B; Harms M; Wöll S; Weigandt M; Windbergs M; Lehr CM
    Eur J Pharm Biopharm; 2016 Apr; 101():126-36. PubMed ID: 26876928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalable PLGA microspheres: Tunable lung retention and systemic exposure via polyethylene glycol modification.
    Li J; Zheng H; Xu EY; Moehwald M; Chen L; Zhang X; Mao S
    Acta Biomater; 2021 Mar; 123():325-334. PubMed ID: 33454386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of paclitaxel by polymeric micelles: A comparison of different block length on uptake, permeability and oral bioavailability.
    Sze LP; Li HY; Lai KLA; Chow SF; Li Q; KennethTo KW; Lam TNT; Lee WYT
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110554. PubMed ID: 31627103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
    Metselaar JM; Bruin P; de Boer LW; de Vringer T; Snel C; Oussoren C; Wauben MH; Crommelin DJ; Storm G; Hennink WE
    Bioconjug Chem; 2003; 14(6):1156-64. PubMed ID: 14624629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating functionalized polyethylene glycol lipids into reprecipitated conjugated polymer nanoparticles for bioconjugation and targeted labeling of cells.
    Kandel PK; Fernando LP; Ackroyd PC; Christensen KA
    Nanoscale; 2011 Mar; 3(3):1037-45. PubMed ID: 21152603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.